{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:47Z","timestamp":1762867127222,"version":"3.37.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000781","name":"The European Research Council","doi-asserted-by":"crossref","award":["CoG-2014-646903"],"award-info":[{"award-number":["CoG-2014-646903"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Economy-Competitiveness","award":["SAF-SAF2013-43065"],"award-info":[{"award-number":["SAF-SAF2013-43065"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer, the ISCIII\/FEDER","award":["PI14\/01191-PI13\/00168"],"award-info":[{"award-number":["PI14\/01191-PI13\/00168"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00204-017-1986-x","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:58:23Z","timestamp":1495526303000},"page":"2763-2780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research"],"prefix":"10.1007","volume":"91","author":[{"name":"On behalf of the EFSA WG EPI1 and its other members","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-3864","authenticated-orcid":false,"given":"Olavi","family":"Pelkonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Terron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Hougaard","family":"Bennekou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"issue":"6","key":"1986_CR1","first-page":"2542","volume":"61","author":"FE Alexander","year":"2001","unstructured":"Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61(6):2542\u20132546","journal-title":"Cancer Res"},{"issue":"4","key":"1986_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng.3230","volume":"47","author":"AK Andersson","year":"2015","unstructured":"Andersson AK, Ma J, Wang J, St. Jude Children\u2019s Research Hospital and Washington University Pediatric Cancer Genome Project et al (2015) The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet 47(4):330\u2013337. doi: 10.1038\/ng.3230","journal-title":"Nat Genet"},{"issue":"1","key":"1986_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2010.07.043","volume":"399","author":"AM Azarova","year":"2010","unstructured":"Azarova AM, Lin RK, Tsai YC, Liu LF, Lin CP, Lyu YL (2010) Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Biochem Biophys Res Commun 399(1):66\u201371. doi: 10.1016\/j.bbrc.2010.07.043","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1986_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/cancers4030904","volume":"4","author":"E Ballabio","year":"2012","unstructured":"Ballabio E, Milne TA (2012) Molecular and epigenetic mechanisms of MLL in human leukemogenesis. Cancers (Basel). 4(3):904\u2013944. doi: 10.3390\/cancers4030904","journal-title":"Cancers (Basel)."},{"issue":"2","key":"1986_CR5","doi-asserted-by":"publisher","first-page":"e955330","DOI":"10.1080\/23723548.2014.955330","volume":"1","author":"E Ballabio","year":"2014","unstructured":"Ballabio E, Milne TA (2014) Epigenetic control of gene expression in leukemogenesis: cooperation between wild type MLL and MLL fusion proteins. Mol Cell Oncol. 1(2):e955330. doi: 10.1080\/23723548.2014.955330","journal-title":"Mol Cell Oncol."},{"issue":"20","key":"1986_CR6","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1021\/bi7000664","volume":"46","author":"OJ Bandele","year":"2007","unstructured":"Bandele OJ, Osheroff N (2007) Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 46(20):6097\u20136108","journal-title":"Biochemistry"},{"key":"1986_CR7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/tx8000785","volume":"21","author":"OJ Bandele","year":"2008","unstructured":"Bandele OJ, Clawson SJ, Osheroff N (2008) Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem Res Toxicol 21:1253\u20131260","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"1986_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/leu.2014.154","volume":"29","author":"M Bardini","year":"2015","unstructured":"Bardini M, Woll PS, Corral L, Luc S, Wittmann L, Ma Z, Lo Nigro L, Basso G, Biondi A, Cazzaniga G, Jacobsen SE (2015) Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement. Leukemia 29(1):38\u201350. doi: 10.1038\/leu.2014.154","journal-title":"Leukemia"},{"issue":"12","key":"1986_CR9","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.celrep.2015.12.003","volume":"13","author":"JM Benito","year":"2015","unstructured":"Benito JM, Godfrey L, Kojima K, Hogdal L, Wunderlich M, Geng H, Marzo I, Harutyunyan KG, Golfman L, North P, Kerry J, Ballabio E, Chonghaile TN, Gonzalo O, Qiu Y, Jeremias I, Debose L, O\u2019Brien E, Ma H, Zhou P, Jacamo R, Park E, Coombes KR, Zhang N, Thomas DA, O\u2019Brien S, Kantarjian HM, Leverson JD, Kornblau SM, Andreeff M, M\u00fcschen M, Zweidler-McKay PA, Mulloy JC, Letai A, Milne TA, Konopleva M (2015) MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199. Cell Rep. 13(12):2715\u20132727. doi: 10.1016\/j.celrep.2015.12.003","journal-title":"Cell Rep."},{"issue":"1","key":"1986_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1096\/fj.03-0638fje","volume":"18","author":"JG Blanco","year":"2004","unstructured":"Blanco JG, Edick MJ, Relling MV (2004) Etoposide induces chimeric Mll gene fusions. FASEB J 18(1):173\u2013175. doi: 10.1096\/fj.03-0638fje","journal-title":"FASEB J"},{"issue":"5","key":"1986_CR11","doi-asserted-by":"crossref","first-page":"F436","DOI":"10.1136\/fn.88.5.F436","volume":"88","author":"A Borkhardt","year":"2003","unstructured":"Borkhardt A, Wilda M, Fuchs U, Gortner L, Reiss I (2003) Congenital leukaemia after heavy abuse of permethrin during pregnancy. Arch Dis Child Fetal Neonatal Ed 88(5):F436\u2013F437","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"1986_CR12","doi-asserted-by":"publisher","first-page":"e0136644","DOI":"10.1371\/journal.pone.0136644","volume":"10","author":"EH Breese","year":"2015","unstructured":"Breese EH, Buechele C, Dawson C, Cleary ML, Porteus MH (2015) Use of genome engineering to create patient specific MLL translocations in primary human hematopoietic stem and progenitor cells. PLoS ONE 10(9):e0136644. doi: 10.1371\/journal.pone.0136644","journal-title":"PLoS ONE"},{"issue":"14","key":"1986_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/blood-2015-05-646398","volume":"126","author":"C Buechele","year":"2015","unstructured":"Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML (2015) MLL leukemia induction by genome editing of human CD34\u00a0+\u00a0hematopoietic cells. Blood 126(14):1683\u20131694. doi: 10.1182\/blood-2015-05-646398","journal-title":"Blood"},{"issue":"9","key":"1986_CR14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/carcin\/bgp169","volume":"30","author":"C Bueno","year":"2009","unstructured":"Bueno C, Catalina P, Melen GJ, Montes R, Sanchez L, Ligero G, Garcia-Perez JL, Menendez P (2009) Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 30(9):1628\u20131637. doi: 10.1093\/carcin\/bgp169","journal-title":"Carcinogenesis"},{"issue":"17","key":"1986_CR15","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","volume":"115","author":"A Bursen","year":"2010","unstructured":"Bursen A, Schwabe K, Ruster B et al (2010) The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Blood 115(17):3570\u20133579","journal-title":"Blood"},{"key":"1986_CR16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8938","author":"J Castano","year":"2016","unstructured":"Castano J, Herrero AB, Bursen A, Gonzalez F, Marschalek R, Gutierrez NC, Menendez P (2016) Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair. Oncotarget. doi: 10.18632\/oncotarget.8938","journal-title":"Oncotarget."},{"key":"1986_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exphem.2015.05.012","volume":"43","author":"C-W Chen","year":"2015","unstructured":"Chen C-W, Armstrong SA (2015) Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond. Exp Hematol 43:673\u2013684","journal-title":"Exp Hematol"},{"issue":"2","key":"1986_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","volume":"108","author":"W Chen","year":"2006","unstructured":"Chen W, Li Q, Hudson WA, Kumar A, Kirchhof N, Kersey JH (2006) A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood 108(2):669\u2013677. doi: 10.1182\/blood-2005-08-3498","journal-title":"Blood"},{"key":"1986_CR19","doi-asserted-by":"crossref","unstructured":"Choi J, Polcher A, Joas A (2016) Systematic literature review on Parkinson\u2019s disease and Childhood Leukaemia and mode of actions for pesticides. EFSA supporting publication: EN-955, 256\u00a0pp","DOI":"10.2903\/sp.efsa.2016.EN-955"},{"issue":"12","key":"1986_CR20","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/ijerph9062075","volume":"9","author":"IG Cowell","year":"2012","unstructured":"Cowell IG, Austin CA (2012) Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int J Environ Res Public Health 9(12):2075\u20132091","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"1986_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.leukres.2011.04.010","volume":"35","author":"RA Chica de la","year":"2011","unstructured":"de la Chica RA, Mediano C, Salido M, Espinet B, Manresa JM, Sol\u00e9 F (2011) Increased MLL gene rearrangements in amniocytes from fetuses of mothers who smoke. Leuk Res 35(8):1066\u20131069. doi: 10.1016\/j.leukres.2011.04.010","journal-title":"Leuk Res"},{"issue":"10","key":"1986_CR22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/gcc.22090","volume":"52","author":"SE Dobbins","year":"2013","unstructured":"Dobbins SE, Sherborne AL, Ma YP, Bardini M, Biondi A, Cazzaniga G, Lloyd A, Chubb D, Greaves MF, Houlston RS (2013) The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia. Genes Chromosomes Cancer 52(10):954\u2013960. doi: 10.1002\/gcc.22090 Epub 2013 Jul 26","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"1986_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3324\/haematol.2012.067983","volume":"98","author":"EM Driessen","year":"2013","unstructured":"Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW (2013) Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Haematologica 98(6):937\u2013944. doi: 10.3324\/haematol.2012.067983","journal-title":"Haematologica"},{"issue":"1","key":"1986_CR24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/jpet.115.228239","volume":"356","author":"SW Edwards","year":"2016","unstructured":"Edwards SW, Tan YM, Villeneuve DL, Meek ME, McQueen CA (2016) Adverse outcome pathways-organizing toxicological information to improve decision making. J Pharmacol Exp Ther 356(1):170\u2013181","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1986_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bjh.13279","volume":"170","author":"M Emerenciano","year":"2015","unstructured":"Emerenciano M, Barbosa TC, de Almeida Lopes B, Meyer C, Marschalek R, Pombo-de-Oliveira MS (2015) Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia. Br J Haematol 170(2):268\u2013271. doi: 10.1111\/bjh.13279","journal-title":"Br J Haematol"},{"key":"1986_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00062752-200207000-00004","volume":"9","author":"P Ernest","year":"2002","unstructured":"Ernest P, Wang J, Korsmeyer SJ (2002) The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 9:282\u2013287","journal-title":"Curr Opin Hematol"},{"key":"1986_CR27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1534-5807(04)00061-9","volume":"6","author":"P Ernest","year":"2004","unstructured":"Ernest P, Fisher JK, Avery W, Sade S, Foy D, Korsmeyer SJ (2004) Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 6:437\u2013443","journal-title":"Dev Cell"},{"issue":"7","key":"1986_CR28","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/ijerph9072444","volume":"9","author":"S Ezoe","year":"2012","unstructured":"Ezoe S (2012) Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health. 9(7):2444\u20132453. doi: 10.3390\/ijerph9072444","journal-title":"Int J Environ Res Public Health."},{"key":"1986_CR29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrrev.2016.03.005","volume":"768","author":"Z Farooq","year":"2016","unstructured":"Farooq Z, Banday S, Pandita TK, Altaf M (2016) The many faces of histone H3K79 methylation. Mutat Res, Rev Mutat Res 768:46\u201352","journal-title":"Mutat Res, Rev Mutat Res"},{"issue":"9\u201310","key":"1986_CR30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.dnarep.2006.05.031","volume":"5","author":"CA Felix","year":"2006","unstructured":"Felix CA, Kolaris CP, Osheroff N (2006) Topoisomerase II and the etiology of chromosomal translocations. DNA Repair (Amst). 5(9\u201310):1093\u20131108","journal-title":"DNA Repair (Amst)."},{"issue":"2","key":"1986_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1289\/ehp.1103942","volume":"121","author":"JD Ferreira","year":"2013","unstructured":"Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia (2013) In utero pesticide exposure and leukemia in Brazilian children\u00a0<\u00a02\u00a0years of age. Environ Health Perspect 121(2):269\u2013275. doi: 10.1289\/ehp.1103942","journal-title":"Environ Health Perspect"},{"issue":"6427","key":"1986_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/363358a0","volume":"363","author":"AM Ford","year":"1993","unstructured":"Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC et al (1993) In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363(6427):358\u2013360. doi: 10.1038\/363358a0","journal-title":"Nature"},{"issue":"28","key":"1986_CR33","doi-asserted-by":"crossref","first-page":"17643","DOI":"10.1074\/jbc.273.28.17643","volume":"273","author":"JM Fortune","year":"1998","unstructured":"Fortune JM, Osheroff N (1998) Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage. J Biol Chem 273(28):17643\u201317650","journal-title":"J Biol Chem"},{"issue":"25","key":"1986_CR34","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","volume":"94","author":"KB Gale","year":"1997","unstructured":"Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB et al (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94(25):13950\u201313954","journal-title":"Proc Natl Acad Sci USA"},{"key":"1986_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.exphem.2016.11.003","volume":"47","author":"L Godfrey","year":"2017","unstructured":"Godfrey L, Kerry J, Thorne R, Repapi E, Davies JO, Tapia M, Ballabio E, Hughes JR, Geng H, Konopleva M, Milne TA (2017) MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27\u00a0acetylation. Exp Hematol 47:64\u201375. doi: 10.1016\/j.exphem.2016.11.003","journal-title":"Exp Hematol"},{"issue":"3","key":"1986_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fcell.2015.00041","volume":"25","author":"B Gole","year":"2015","unstructured":"Gole B, Wiesm\u00fcller L (2015) Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism. Front Cell Dev Biol. 25(3):41. doi: 10.3389\/fcell.2015.00041","journal-title":"Front Cell Dev Biol."},{"issue":"5","key":"1986_CR37","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1021\/acs.chemrestox.5b00009","volume":"28","author":"ON Gordon","year":"2015","unstructured":"Gordon ON, Luis PB, Ashley RE, Osheroff N, Schneider C (2015) Oxidative transformation of demethoxy- and bisdemethoxycurcumin: products, mechanism of formation, and poisoning of human topoisomerase II\u03b2. Chem Res Toxicol 28(5):989\u2013996. doi: 10.1021\/acs.chemrestox.5b00009","journal-title":"Chem Res Toxicol"},{"key":"1986_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.324.7332.283","volume":"324","author":"M Greaves","year":"2002","unstructured":"Greaves M (2002) Childhood leukaemia. BMJ 324:283\u2013287","journal-title":"BMJ"},{"issue":"4","key":"1986_CR39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccell.2015.03.016","volume":"27","author":"M Greaves","year":"2015","unstructured":"Greaves M (2015) When one mutation is all it takes. Cancer Cell 27(4):433\u2013434","journal-title":"Cancer Cell"},{"key":"1986_CR40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/ijms17040461","volume":"17","author":"AF Hern\u00e1ndez","year":"2016","unstructured":"Hern\u00e1ndez AF, Men\u00e9ndez P (2016) Linking pesticide exposure with pediatric leukemia: potential underlying mechanisms. Int J Mol Sci 17:461","journal-title":"Int J Mol Sci"},{"key":"1986_CR41","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V90.5.1799","volume":"90","author":"JL Hess","year":"1997","unstructured":"Hess JL, Yu BD, Li B, Hanson RD, Korsmeyer SJ (1997) Defect in yolk sac hematopoiesis in mll-null embryos. Blood 90:1799\u20131806","journal-title":"Blood"},{"key":"1986_CR42","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"73","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 73:1541\u20131552","journal-title":"N Engl J Med"},{"issue":"1","key":"1986_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02982722","volume":"76","author":"E Ishii","year":"2002","unstructured":"Ishii E, Eguchi M, Eguchi-Ishimae M, Yoshida N, Oda M, Zaitsu M et al (2002) In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells. Int J Hematol 76(1):74\u201379","journal-title":"Int J Hematol"},{"issue":"4","key":"1986_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.leu.2404578","volume":"21","author":"MW Jansen","year":"2007","unstructured":"Jansen MW, Corral L, van der Velden VH, Panzer-Grumayer R, Schrappe M, Schrauder A et al (2007) Immunobiological diversity in infant acute lymphoblastic leukemiais related to the occurence and type of MLL rearrangment. Leukemia 21(4):633\u2013641","journal-title":"Leukemia"},{"issue":"1","key":"1986_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12094-010-0460-5","volume":"12","author":"M Joannides","year":"2010","unstructured":"Joannides M, Grimwade D (2010) Molecular biology of therapy-related leukaemias. Clin Transl Oncol 12(1):8\u201314. doi: 10.1007\/s12094-010-0460-5","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1986_CR46","doi-asserted-by":"publisher","first-page":"e2011045","DOI":"10.4084\/MJHID.2011.045","volume":"3","author":"M Joannides","year":"2011","unstructured":"Joannides M, Mays AN, Mistry AR, Hasan SK, Reiter A, Wiemels JL, Felix CA, Coco FL, Osheroff N, Solomon E, Grimwade D (2011) Molecular pathogenesis of secondary acute promyelocytic leukemia. Mediterr J Hematol Infect Dis 3(1):e2011045. doi: 10.4084\/MJHID.2011.045","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"1986_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.celrep.2016.12.054","volume":"18","author":"J Kerry","year":"2017","unstructured":"Kerry J, Godfrey L, Repapi E, Tapia M, Blackledge NP, Ma H, Ballabio E, O\u2019Byrne S, Ponthan F, Heidenreich O, Roy A, Roberts I, Konopleva M, Klose RJ, Geng H, Milne TA (2017) MLL-AF4 spreading identifies binding sites that are distinct from super-enhancers and that govern sensitivity to DOT1L inhibition in leukemia. Cell Rep. 18(2):482\u2013495. doi: 10.1016\/j.celrep.2016.12.054","journal-title":"Cell Rep."},{"issue":"1","key":"1986_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11101-013-9291-7","volume":"13","author":"AC Ketron","year":"2014","unstructured":"Ketron AC, Osheroff N (2014) Phytochemicals as anticancer and chemopreventive topoisomerase II poisons. Phytochem Rev 13(1):19\u201335","journal-title":"Phytochem Rev"},{"key":"1986_CR49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bi3014455","volume":"52","author":"AC Ketron","year":"2013","unstructured":"Ketron AC, Gordon ON, Schneider C, Osheroff N (2013) Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry 52:221\u2013227","journal-title":"Biochemistry"},{"issue":"11","key":"1986_CR50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","volume":"7","author":"AV Krivtsov","year":"2007","unstructured":"Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7(11):823\u2013833","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1986_CR51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","volume":"14","author":"AV Krivtsov","year":"2008","unstructured":"Krivtsov AV, Feng Z, Lemieux ME et al (2008) H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14(5):355\u2013368","journal-title":"Cancer Cell"},{"issue":"1","key":"1986_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1258\/ebm.2009.009184","volume":"235","author":"L Lanoue","year":"2010","unstructured":"Lanoue L, Green KK, Kwik-Uribe C, Keen CL (2010) Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity. Exp Biol Med (Maywood). 235(1):77\u201389. doi: 10.1258\/ebm.2009.009184","journal-title":"Exp Biol Med (Maywood)."},{"issue":"10","key":"1986_CR53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.11034","volume":"92","author":"G Leone","year":"2007","unstructured":"Leone G, Pagano L, Ben-Yehuda D, Voso MT (2007) Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 92(10):1389\u20131398","journal-title":"Haematologica"},{"issue":"2","key":"1986_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/toxsci\/kft259","volume":"137","author":"Z Li","year":"2014","unstructured":"Li Z, Sun B, Clewell RA, Adeleye Y, Andersen ME, Zhang Q (2014) Dose\u2013response modeling of etoposide-induced DNA damage response. Toxicol Sci 137(2):371\u2013384. doi: 10.1093\/toxsci\/kft259","journal-title":"Toxicol Sci"},{"issue":"5","key":"1986_CR55","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1182\/blood-2004-07-2683","volume":"105","author":"J Libura","year":"2005","unstructured":"Libura J, Slater DJ, Felix CA, Richardson C (2005) Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34\u00a0+\u00a0cells and remain stable after clonal expansion. Blood 105(5):2124\u20132131. doi: 10.1182\/blood-2004-07-2683","journal-title":"Blood"},{"issue":"3","key":"1986_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-0609.2008.01103.x","volume":"81","author":"J Libura","year":"2008","unstructured":"Libura J, Ward M, Solecka J, Richardson C (2008) Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. Eur J Haematol 81(3):185\u2013195. doi: 10.1111\/j.1600-0609.2008.01103.x","journal-title":"Eur J Haematol"},{"key":"1986_CR57","doi-asserted-by":"crossref","first-page":"33591","DOI":"10.1074\/jbc.M111.258137","volume":"286","author":"RK Lin","year":"2011","unstructured":"Lin RK, Zhou N, Lyu YL, Tsai YC, Lu CH, Kerrigan J, Chen YT, Guan Z, Hsieh TS, Liu LF (2011) Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase II\u03b1. J Biol Chem 286:33591\u201333600","journal-title":"J Biol Chem"},{"issue":"5","key":"1986_CR58","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","volume":"30","author":"S Lin","year":"2016","unstructured":"Lin S, Luo RT, Ptasinska A, Kerry J, Assi SA, Wunderlich M, Imamura T, Kaberlein JJ, Rayes A, Althoff MJ, Anastasi J, O\u2019Brien MM, Meetei AR, Milne TA, Bonifer C, Mulloy JC, Thirman MJ (2016) Instructive role of MLL-fusion proteins revealed by a model of t(4;11) Pro-B acute lymphoblastic leukemia. Cancer Cell 30(5):737\u2013749. doi: 10.1016\/j.ccell.2016.10.008","journal-title":"Cancer Cell"},{"issue":"1","key":"1986_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mrgentox.2009.12.010","volume":"696","author":"M Lopez-Lazaro","year":"2010","unstructured":"Lopez-Lazaro M, Willmore E, Austin CA (2010) The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat Res 696(1):41\u201347. doi: 10.1016\/j.mrgentox.2009.12.010","journal-title":"Mutat Res"},{"issue":"2","key":"1986_CR60","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/toxsci\/kfv153","volume":"147","author":"C Lu","year":"2015","unstructured":"Lu C, Liu X, Liu C, Wang J, Li C, Liu Q, Li Y, Li S, Sun S, Yan J, Shao J (2015) Chlorpyrifos induces MLL tra nslocations through caspase 3-dependent genomic instability and topoisomerase II inhibition in human fetal liver hematopoietic stem cells. Toxicol Sci 147(2):588\u2013606. doi: 10.1093\/toxsci\/kfv153","journal-title":"Toxicol Sci"},{"issue":"2","key":"1986_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","volume":"124","author":"E Manara","year":"2014","unstructured":"Manara E, Baron E, Tregnago C, Aveic S, Bisio V, Bresolin S, Masetti R, Locatelli F, Basso G, Pigazzi M (2014) MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. Blood 124(2):263\u2013272. doi: 10.1182\/blood-2013-09-525741","journal-title":"Blood"},{"issue":"152","key":"1986_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2141.08459.x","volume":"2010","author":"R Marschalek","year":"2010","unstructured":"Marschalek R (2010) Mechanisms of leukemogenesis by MLL fusion proteins. Brit J Haematol 2010(152):141\u2013154. doi: 10.1111\/j.1365-2141.08459.x","journal-title":"Brit J Haematol"},{"issue":"1\u20132","key":"1986_CR63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mrfmmm.2007.06.009","volume":"623","author":"AK McClendon","year":"2007","unstructured":"McClendon AK, Osheroff N (2007) DNA topoisomerase II, genotoxicity and cancer. Mutation Res 623(1\u20132):83\u201397","journal-title":"Mutation Res"},{"issue":"1","key":"1986_CR64","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2015-11-683334","volume":"128","author":"T McKerrell","year":"2016","unstructured":"McKerrell T, Moreno T, Ponstingl H, Bolli N, Dias JM, Tischler G, Colonna V, Manasse B, Bench A, Bloxham D, Herman B, Fletcher D, Park N, Quail MA, Manes N, Hodkinson C, Baxter J, Sierra J, Foukaneli T, Warren AJ, Chi J, Costeas P, Rad R, Huntly B, Grove C, Ning Z, Tyler-Smith C, Varela I, Scott M, Nomdedeu J, Mustonen V, Vassiliou GS (2016) Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies. Blood 128(1):e1\u2013e9. doi: 10.1182\/blood-2015-11-683334","journal-title":"Blood"},{"issue":"13","key":"1986_CR65","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1084\/jem.20091050","volume":"206","author":"P Menendez","year":"2009","unstructured":"Menendez P, Catalina P, Rodriguez R, Melen GJ, Bueno C, Arriero M, Garcia-Sanchez F, Lassaletta A, Garcia-Sanz R, Garcia-Castro J (2009) Bone marrow mesenchymal stem cells from infants with MLL-AF4\u00a0+\u00a0acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 206(13):3131\u20133141. doi: 10.1084\/jem.20091050","journal-title":"J Exp Med"},{"issue":"22","key":"1986_CR66","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","volume":"25","author":"M Metzler","year":"2006","unstructured":"Metzler M, Forster A, Pannell R et al (2006) A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology. Oncogene 25(22):3093\u20133103","journal-title":"Oncogene"},{"issue":"11","key":"1986_CR67","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","volume":"27","author":"C Meyer","year":"2013","unstructured":"Meyer C, Hofmann J, Burmeister T et al (2013) The MLL recombinome of acute leukemias in 2013. Leukemia 27(11):2165\u20132176","journal-title":"Leukemia"},{"issue":"15","key":"1986_CR68","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa042715","volume":"352","author":"AR Mistry","year":"2005","unstructured":"Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Ades L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D (2005) DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 352(15):1529\u20131538","journal-title":"N Engl J Med"},{"issue":"4","key":"1986_CR69","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/carcin\/bgi322","volume":"27","author":"CG Moneypenny","year":"2006","unstructured":"Moneypenny CG, Shao J, Song Y, Gallagher EP (2006) MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells. Carcinogenesis 27(4):874\u2013881. doi: 10.1093\/carcin\/bgi322 (Epub 2005\/12\/27)","journal-title":"Carcinogenesis"},{"issue":"14","key":"1986_CR70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17179\/excli2015-561","volume":"19","author":"A Montecucco","year":"2015","unstructured":"Montecucco A, Zanetta F, Biamonti G (2015) Molecular mechanisms of etoposide. EXCLI J. 19(14):95\u2013108. doi: 10.17179\/excli2015-561","journal-title":"EXCLI J."},{"issue":"4","key":"1986_CR71","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.stemcr.2016.08.013","volume":"7","author":"A Munoz-Lopez","year":"2016","unstructured":"Munoz-Lopez A, Romero-Moya D, Prieto C, Ramos-Meji-a V, Agraz-Doblas A, Varela I, Buschbeck M, Palau A, Carvajal-Vergara X, Giorgetti A, Ford A, Lako M, Granada I, Rodri-guez-Perales S, Ruiz-Xiville, Torres-Rui-z R, Stam RW, Fuster JL, Fraga MF, Nakanishi M, Cazzaniga G, Bardini M, Cobo I, Bayon GF, Fernandez AF, Bueno C, Menendez P (2016) Development refractoriness of MLL-rearranged human B cell acute leukemias to reprogramming into pluripotency. Stem Cell Rep 7(4):602\u2013618. doi: 10.1016\/j.stemcr.2016.08.013","journal-title":"Stem Cell Rep"},{"issue":"12","key":"1986_CR72","doi-asserted-by":"publisher","first-page":"e0144540","DOI":"10.1371\/journal.pone.0144540","volume":"10","author":"M Nanya","year":"2015","unstructured":"Nanya M, Sato M, Tanimoto K, Tozuka M, Mizutani S, Takagi M (2015) Dysregulation of the DNA damage response and KMT2A rearrangement in fetal liver hematopoietic cells. PLoS ONE 10(12):e0144540. doi: 10.1371\/journal.pone.0144540","journal-title":"PLoS ONE"},{"issue":"11","key":"1986_CR73","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","volume":"99","author":"CM Niemeyer","year":"2014","unstructured":"Niemeyer CM (2014) RAS diseases in children. Haematologica 99(11):1653\u20131662","journal-title":"Haematologica"},{"key":"1986_CR74","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 9:338\u2013350","journal-title":"Nat Rev Cancer"},{"key":"1986_CR75","doi-asserted-by":"crossref","unstructured":"Ntzani EE, Chondrogiorgi M, Ntritsos G, Evangelou E and Tzoulaki I (2013) Literature review on epidemiological studies linking exposure to pesticides and health effects. EFSA supporting publication 2013: EN-497, 159\u00a0pp","DOI":"10.2903\/sp.efsa.2013.EN-497"},{"issue":"3","key":"1986_CR76","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.2903\/j.efsa.2017.4691","volume":"15","author":"C Ockleford","year":"2017","unstructured":"Ockleford C, Adriaanse P, Berny P, Brock T, Duquesne S, Grilli S, Hernandez-Jerez AF, Bennekou SH, Klein M, Kuhl T, Laskowski R, Machera K, Pelkonen O, Pieper S, Smith R, Stemmer M, Sundh I, Teodorovic I, Tiktak A, Topping CJ, Wolterink G, Angeli K, Fritsche E, Hernandez-Jerez AF, Leist M, Mantovani A, Menendez P, Pelkonen O, Price A, Viviani B, Chiusolo A, Ruffo F, Terron A, Bennekou SH, EFSA PPR Panel (EFSA Panel on Plant Protection Products and their Residues) (2017) Scientific opinion on the investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson\u2019s disease and childhood leukaemia. EFSA J 15(3):4691. doi: 10.2903\/j.efsa.2017.4691","journal-title":"EFSA J"},{"key":"1986_CR77","unstructured":"OECD (2013) Guidance document on developing and assessing adverse outcome pathways. ENV\/JM\/MONO(2013) 6"},{"key":"1986_CR78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.yrtph.2015.02.011","volume":"7","author":"G Patlewitz","year":"2015","unstructured":"Patlewitz G, Simon TW, Rowlands JC, Budinsky RA, Becker RA (2015) Proposing a scientific framework to help support the application of adverse outcome pathways for regulatory purposes. Regul Toxicol Pharmacol 7:463\u2013477","journal-title":"Regul Toxicol Pharmacol"},{"key":"1986_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/nyas.12358","volume":"1310","author":"M Pendleton","year":"2014","unstructured":"Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N (2014) Topoisomerase II and leukemia. Ann N Y Acad Sci 1310:98\u2013110. doi: 10.1111\/nyas.12358","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1986_CR80","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1158\/1055-9965.EPI-06-0031","volume":"15","author":"MS Pombo-de-Oliveira","year":"2006","unstructured":"Pombo-de-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 15(12):2336\u20132341","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"1986_CR81","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/leu.2012.365","volume":"27","author":"C Prelle","year":"2012","unstructured":"Prelle C, Bursen A, Dingermann T, Marschalek R (2012) Secondary mutations in t(4;11) leukemia patients. Leukemia 27(6):1425\u20131427","journal-title":"Leukemia"},{"issue":"8","key":"1986_CR82","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/0008-5472","volume":"76","author":"C Prieto","year":"2016","unstructured":"Prieto C, Stam RW, Agraz-Doblas A, Ballerini P, Camos M, Castano J, Marschalek R, Bursen A, Varela I, Bueno C, Menendez P (2016) Activated KRAS cooperates with MLLAF4 to promote extramedullary engraftment and migration of cord blood CD34\u00a0+\u00a0HSPC but is insufficient to initiate leukemia. Cancer Res 76(8):2478\u20132489. doi: 10.1158\/0008-5472","journal-title":"Cancer Res"},{"issue":"3","key":"1986_CR83","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.leu.2400928","volume":"12","author":"MV Relling","year":"1998","unstructured":"Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG, Pui CH (1998) Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 12(3):346\u2013352","journal-title":"Leukemia"},{"issue":"6","key":"1986_CR84","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00051700","volume":"7","author":"JA Ross","year":"1996","unstructured":"Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children\u2019s Cancer Group. Cancer Causes Control 7(6):581\u2013590","journal-title":"Cancer Causes Control"},{"issue":"6","key":"1986_CR85","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/pbc.23274","volume":"58","author":"TN Sam","year":"2012","unstructured":"Sam TN, Kersey JH, Linabery AM, Johnson KJ, Heerema NA, Hilden JM et al (2012) MLL gene rearrangements in infant leukaemia vary with age at diagnosis and selected demographic factors: a Children\u2019s Oncology Group (COG) study. Pediatr Blood Cancer 58(6):836\u2013839","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"1986_CR86","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1182\/blood-2015-09-667378","volume":"126","author":"A Sanjuan-Pla","year":"2015","unstructured":"Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menendez P (2015) Revisiting the biology of infant t(4;11)\/MLL-AF4\u00a0+\u00a0B-cell acute lymphoblastic leukemia. Blood 126(25):2676\u20132685. doi: 10.1182\/blood-2015-09-667378","journal-title":"Blood"},{"key":"1986_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201500352","author":"A Schroeter","year":"2015","unstructured":"Schroeter A, Groh IA, Favero GD, Pignitter M, Schueller K, Somoza V, Marko D (2015) Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Mol Nutr Food Res. doi: 10.1002\/mnfr.201500352","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"1986_CR88","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1055-9965.EPI-04-0602","volume":"14","author":"LG Spector","year":"2005","unstructured":"Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA (2005) Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children\u2019s oncology group. Cancer Epidemiol Biomarkers Prev 14(3):651\u2013655","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1986_CR89","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.070061297","volume":"97","author":"R Strick","year":"2000","unstructured":"Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A. 97(9):4790\u20134795","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1986_CR90","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood.V82.12.3705.3705","volume":"82","author":"HJ Super","year":"1993","unstructured":"Super HJ, McCabe NR, Thirman MJ et al (1993) Rearrangements of the MLL gene in therap-related acute myeloid leukaemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705\u20133711","journal-title":"Blood"},{"issue":"5","key":"1986_CR91","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1272\/jnms.80.326","volume":"80","author":"H Tamai","year":"2013","unstructured":"Tamai H, Inokuchi K (2013) Establishment of MLL\/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma. J Nippon Med Sch. 80(5):326\u2013327","journal-title":"J Nippon Med Sch."},{"issue":"5","key":"1986_CR92","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/leu.2011.15","volume":"25","author":"H Tamai","year":"2011","unstructured":"Tamai H, Miyake K, Takatori M, Miyake N, Yamaguchi H, Dan K, Shimada T, Inokuchi K (2011) Activated K-Ras protein accelerates human MLL\/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model. Leukemia 25(5):888\u2013891. doi: 10.1038\/leu.2011.15","journal-title":"Leukemia"},{"key":"1986_CR93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pathol.4.110807.092227","volume":"4","author":"MA Teitell","year":"2009","unstructured":"Teitell MA, Pandolfi PP (2009) Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol 4:175\u2013198","journal-title":"Annu Rev Pathol"},{"key":"1986_CR94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mrfmmm.2015.06.011","volume":"779","author":"RG Thys","year":"2015","unstructured":"Thys RG, Lehman CE, Pierce LCT, Wang YH (2015) Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem\/progenitor cells. Mutat Res\/Fundam Mol Mech Mutagenesis 779:86\u201395","journal-title":"Mutat Res\/Fundam Mol Mech Mutagenesis"},{"key":"1986_CR95","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yrtph.2014.09.009","volume":"70","author":"KE Tollefsen","year":"2014","unstructured":"Tollefsen KE, Scholz S, Cronin MT, Edwards SW, de Knecht J, Crofton K, Garcia-Reyero N, Hartung T, Worth A, Patlewitz G (2014) Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). Regul Toxiciol Pharmacol 70:629\u2013640","journal-title":"Regul Toxiciol Pharmacol"},{"key":"1986_CR96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2015.12.001","volume":"767","author":"I Udroiu","year":"2012","unstructured":"Udroiu I, Sgura A (2012) Genotoxicity sensitivity of the developing hematopoietic system. 2012. Mutat Res 767:1\u20137","journal-title":"Mutat Res"},{"issue":"8","key":"1986_CR97","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/carcin\/bgm102","volume":"28","author":"SBVW Doorn-Khosrovani van","year":"2007","unstructured":"van Doorn-Khosrovani SBVW, Janssen J, Maas LM, Godschalk RW, Nijhuis JG, van Schooten FJ (2007) Dietary flavonoids induce MLL translocations in primary human CD34\u00a0+\u00a0cells. Carcinogenesis 28(8):1703\u20131709","journal-title":"Carcinogenesis"},{"issue":"1","key":"1986_CR98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/toxsci\/kfq388","volume":"120","author":"K Vanhees","year":"2011","unstructured":"Vanhees K, de Bock L, Godschalk RW, van Schooten FJ, van Doorn-Khosrovani SBVW (2011) Prenatal exposure to flavonoids: implication for cancer risk. Toxicol Sci 120(1):59\u201367. doi: 10.1093\/toxsci\/kfq388","journal-title":"Toxicol Sci"},{"key":"1986_CR99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","volume":"312","author":"M Vinken","year":"2013","unstructured":"Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158\u2013165","journal-title":"Toxicology"},{"key":"1986_CR100","doi-asserted-by":"crossref","first-page":"10632","DOI":"10.1073\/pnas.95.18.10632","volume":"95","author":"BD Yu","year":"1998","unstructured":"Yu BD, Hanson RD, Hess JL, Horning SE, Korsmeyer SJ (1998) MLL, a mammalian trithorax-group gene, functions as atrascriptional maintenance factor in morphogenesis. Proc Natl Acad Sci USA 95:10632\u201310636","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-017-1986-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-1986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-1986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:06:43Z","timestamp":1602144403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-017-1986-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1007\/s00204-017-1986-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}